Niagen Bioscience, Inc.
NAGECIK 0001386570 · last filing Jul 8, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
7,675 bought / 0 sold
net +7,675 sh · +$20.8K
- buys
- 3
- sells
- 0
- insiders active
- 3
Filing tape
Filed Wed, Jul 8, 2026
- +2,314 sh · $6.3K
Lopez Carlos Luis — SVP, General Counsel
- Granted2,314Common Stock@ $2.71→ 4,565 heldtrade dated Jun 30, 2026
- +4,255 sh · $11.5K
Pamir Ozan — Chief Financial Officer
- Granted4,255Common Stock@ $2.71→ 11,627 heldtrade dated Jun 30, 2026
- +1,106 sh · $3.0K
Fried Robert N — Chief Executive Officer · Director
- Granted1,106Common Stock@ $2.71→ 1,060,087 heldtrade dated Jun 30, 2026
Insiders on this tape
- Lopez Carlos LuisSVP, General Counsel
- Pamir OzanChief Financial Officer
- Fried Robert NChief Executive Officer · Director
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.